A detailed history of Second Line Capital, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Second Line Capital, LLC holds 5,483 shares of BMY stock, worth $314,340. This represents 0.08% of its overall portfolio holdings.

Number of Shares
5,483
Holding current value
$314,340
% of portfolio
0.08%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 18, 2024

BUY
$39.66 - $51.75 $217,455 - $283,745
5,483 New
5,483 $284 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $122B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Second Line Capital, LLC Portfolio

Follow Second Line Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Second Line Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Second Line Capital, LLC with notifications on news.